Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair
about
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerContribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma TreatmentsPrediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modelingBoth epidermal growth factor and insulin-like growth factor receptors are dispensable for structural intestinal adaptation.Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitorsL- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activationIntegr(at)in(g) EGFR therapy in HNSCCType I insulin-like growth factor receptor signaling in hematological malignancies.Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells.Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.Insulin-like growth factor-1 receptor regulates repair of ultraviolet B-induced DNA damage in human keratinocytes in vivo.Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.
P2860
Q26766638-F3B20B04-E36F-41BB-85A3-283F0F6833C0Q28547357-7CE8E9B3-FB50-4EC7-A82E-2CBF6CC4BB45Q35544606-C753986E-C738-4DF9-BAAF-20858E06A65DQ35630090-45E7B7DB-755B-47C2-89FF-B9210EC815D5Q35824908-78BE1C00-0CDA-4881-8FA5-734BE7740A69Q35888916-341A2C5B-1D17-4C1B-BB8E-817820B46569Q36403862-C4286AA8-7F45-40D2-95A1-D0F77C5CD58EQ37702186-5877653D-B626-461D-B5F8-17C2233A5C79Q38866417-65582715-604C-4C9F-BF5E-191B1B5422CCQ38911597-8A564856-52EE-4676-BD89-89B81E107838Q38927489-1F7BE35C-7852-4D9F-AF82-858C27341A7EQ38943947-B2B8D11C-0E20-4BA3-BC68-D7D4CC1C8760Q41113979-5EB0ABD4-276A-414B-8994-CECFF5750F56Q55036871-165BBFE6-992B-494C-96F7-82E75846CB31
P2860
Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inhibition of both EGFR and IG ...... omologous recombination repair
@ast
Inhibition of both EGFR and IG ...... omologous recombination repair
@en
Inhibition of both EGFR and IG ...... omologous recombination repair
@nl
type
label
Inhibition of both EGFR and IG ...... omologous recombination repair
@ast
Inhibition of both EGFR and IG ...... omologous recombination repair
@en
Inhibition of both EGFR and IG ...... omologous recombination repair
@nl
prefLabel
Inhibition of both EGFR and IG ...... omologous recombination repair
@ast
Inhibition of both EGFR and IG ...... omologous recombination repair
@en
Inhibition of both EGFR and IG ...... omologous recombination repair
@nl
P2093
P2860
P1433
P1476
Inhibition of both EGFR and IG ...... omologous recombination repair
@en
P2093
Chang Hong Shi
Cheng Gang Yi
Guang Feng Zhu
Jian Jun Ma
Jian Lin Yuan
Jing Yu Gao
Juan Ying Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0068784
P407
P577
2013-08-12T00:00:00Z